Syneos Health
LEI 549300F1ZGKDS8P6GU13
Upgrade to Premium features
Cbonds consolidates global bond, stock, ETF and indices data into a single platform — so you can analyze faster, make informed investment decisions and outperform the market
Get access-
Full access to the largest bond database
Bond parameters,
prospectuses -
Seamless
Data exportAnalyze the data in the most efficient way
-
Bond pricing
Current & historical quotes from 400+ stock exchanges & OTC market
-
Smart risk assessment
Credit ratings, financial reports
Trading Schedule Issuer map
Quotes
- «
- 1
- ...
- {{ quotes.page - 2 }}
- {{ quotes.page - 1 }}
- {{ quotes.page }}
- {{ quotes.page + 1 }}
- {{ quotes.page + 2 }}
- ...
- {{ quotesLastPage }}
- »
Profile
|
INC Research, LLC, a contract research organization, provides phase II and III clinical research, and pharma consulting services worldwide.
On August 1, 2017 INC Research, LLC completed a merger with inVentiv Health, Inc., the new entity's name becoming INC Research/inVentiv Health (on a provisional basis). As for that period, the Company's shares continued trading on NASDAQ under the same ticker - INCR.
On February 4, 2018 the Company changed its name to Syneos Health, Inc., its ticker changed on NASDAQ from INCR to SYNH.
|
General information
-
Organization nameSyneos Health, Inc.
-
Organization statusOperating organization
-
Address3201 Beechleaf Court Suite 600 Raleigh, USA, 27604
-
Site
-
IR Site
News
IFRS/US GAAP reports
| 2023 | |
| 2022 | |
| 2021 | |
| 2020 | |
| 2019 | |
| 2018 | |
| 2017 | |
| 2016 | |
| 2015 | |
| 2014 | |
Stocks
General information
-
Organization nameSyneos Health, Inc.
-
Organization statusOperating organization
-
Address3201 Beechleaf Court Suite 600 Raleigh, USA, 27604
-
Site
-
IR Site
Codes
-
LEI549300F1ZGKDS8P6GU13
-
SIC8731 SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH
-
NACE*** ***
-
NAICS*** ***
-
CIK0001610950









